[go: up one dir, main page]

IS4975A - Aðferð til meðhöndlunar á hjartabilun - Google Patents

Aðferð til meðhöndlunar á hjartabilun

Info

Publication number
IS4975A
IS4975A IS4975A IS4975A IS4975A IS 4975 A IS4975 A IS 4975A IS 4975 A IS4975 A IS 4975A IS 4975 A IS4975 A IS 4975A IS 4975 A IS4975 A IS 4975A
Authority
IS
Iceland
Prior art keywords
treatment
heart failure
heart
failure
Prior art date
Application number
IS4975A
Other languages
English (en)
Inventor
Liang Chen Yuhpyng
Andrea Fossa Anthony
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS4975A publication Critical patent/IS4975A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS4975A 1998-02-17 1999-02-11 Aðferð til meðhöndlunar á hjartabilun IS4975A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7493498P 1998-02-17 1998-02-17

Publications (1)

Publication Number Publication Date
IS4975A true IS4975A (is) 1999-08-18

Family

ID=22122537

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4975A IS4975A (is) 1998-02-17 1999-02-11 Aðferð til meðhöndlunar á hjartabilun

Country Status (28)

Country Link
US (1) US6043260A (is)
EP (1) EP0951906A1 (is)
JP (1) JPH11292766A (is)
KR (1) KR19990072616A (is)
CN (1) CN1231176A (is)
AP (1) AP9901464A0 (is)
AR (1) AR017723A1 (is)
AU (1) AU1732999A (is)
BG (1) BG103180A (is)
BR (1) BR9900653A (is)
CA (1) CA2262252C (is)
EA (1) EA199900124A3 (is)
GT (1) GT199900015A (is)
HR (1) HRP990054A2 (is)
HU (1) HUP9900386A3 (is)
ID (1) ID23218A (is)
IL (1) IL128531A0 (is)
IS (1) IS4975A (is)
MA (1) MA26608A1 (is)
NO (1) NO990722L (is)
OA (1) OA10976A (is)
PA (1) PA8467401A1 (is)
PE (1) PE20000266A1 (is)
PL (1) PL331507A1 (is)
SG (1) SG81261A1 (is)
TN (1) TNSN99024A1 (is)
TR (1) TR199900328A2 (is)
ZA (1) ZA991220B (is)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403599B1 (en) 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
US6956047B1 (en) 1995-06-06 2005-10-18 Pfizer Inc. Corticotropin releasing factor antagonists
US7067664B1 (en) 1995-06-06 2006-06-27 Pfizer Inc. Corticotropin releasing factor antagonists
US6387894B1 (en) * 1999-06-11 2002-05-14 Pfizer Inc. Use of CRF antagonists and renin-angiotensin system inhibitors
AU3885901A (en) * 1999-09-21 2001-04-24 Emory University Methods and compositions for treating platelet-related disorders
KR20020063934A (ko) * 2000-01-18 2002-08-07 화이자 프로덕츠 인코포레이티드 코르티코트로핀 방출 인자 길항제
GB0027410D0 (en) * 2000-11-09 2000-12-27 Pfizer Ltd Mutual prodrug of amlodipine and atorvastatin
US6737430B2 (en) 2000-11-09 2004-05-18 Pfizer, Inc. Mutual prodrug of amlodipine and atorvastatin
US6992087B2 (en) 2001-11-21 2006-01-31 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
JP2005532268A (ja) 2002-02-22 2005-10-27 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 置換されたピリミジノンおよびピリミジンチオン
WO2003078435A1 (en) * 2002-03-13 2003-09-25 Pharmacia & Upjohn Company Llc Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
JP2005533014A (ja) * 2002-04-26 2005-11-04 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 置換ピラジン誘導体
MXPA05002418A (es) * 2002-09-12 2005-05-27 Pharmacia & Upjohn Co Llc Derivados de 1,4-pirazina sustituidos.
AR041470A1 (es) * 2002-10-17 2005-05-18 Upjohn Co Compuestos de pirrolo (1,2 - b) piridazina y sus usos
AU2003278542A1 (en) * 2002-11-21 2004-06-15 Pharmacia & Upjohn Company Llc Pyrazine compounds as crf modulators
EP1620428A1 (en) * 2003-04-23 2006-02-01 Pharmacia & Upjohn Company LLC Substituted pyrimidinones and pyrimidinthiones as crf antagonists
EP1622911A2 (en) * 2003-05-07 2006-02-08 Pharmacia & Upjohn Company LLC Pyrrolo[1,2-b]pyridazine compounds and their use as crf-1 receptor antagonists
EP1625125A1 (en) * 2003-05-09 2006-02-15 Pharmacia & Upjohn Company LLC Compounds as crf1 receptor antagonists
BRPI0410127A (pt) * 2003-05-09 2006-05-09 Pharmacia & Upjohn Co Llc derivados de pirimidina substituìdos
MXPA05012087A (es) * 2003-05-09 2006-02-22 Pharmacia & Upjohn Co Llc Nuevas pirazinonas como antagonistas del receptor crf1.
WO2005089639A2 (en) * 2004-03-16 2005-09-29 Talarico M D Matthew T Method for vascular dysregulation
US20060211710A1 (en) * 2005-03-17 2006-09-21 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
US8338441B2 (en) * 2009-05-15 2012-12-25 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW574214B (en) * 1994-06-08 2004-02-01 Pfizer Corticotropin releasing factor antagonists
US6403599B1 (en) * 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
EP0795327A1 (en) * 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin

Also Published As

Publication number Publication date
TNSN99024A1 (fr) 2005-11-10
TR199900328A2 (xx) 1999-10-21
CA2262252C (en) 2006-01-10
CN1231176A (zh) 1999-10-13
JPH11292766A (ja) 1999-10-26
EA199900124A2 (ru) 1999-08-26
MA26608A1 (fr) 2004-12-20
NO990722D0 (no) 1999-02-16
BR9900653A (pt) 2000-10-17
ID23218A (id) 2000-03-30
HUP9900386A3 (en) 1999-12-28
OA10976A (en) 2001-11-05
PE20000266A1 (es) 2000-04-07
PL331507A1 (en) 1999-08-30
ZA991220B (en) 2000-08-16
NO990722L (no) 1999-08-18
AR017723A1 (es) 2001-09-12
US6043260A (en) 2000-03-28
KR19990072616A (ko) 1999-09-27
PA8467401A1 (es) 2000-09-29
IL128531A0 (en) 2000-01-31
EA199900124A3 (ru) 1999-12-29
HRP990054A2 (en) 2000-02-29
BG103180A (bg) 1999-09-30
CA2262252A1 (en) 1999-08-17
EP0951906A1 (en) 1999-10-27
HU9900386D0 (en) 1999-04-28
GT199900015A (es) 2000-07-26
AU1732999A (en) 1999-09-02
AP9901464A0 (en) 1999-03-31
SG81261A1 (en) 2001-06-19
HUP9900386A2 (hu) 1999-11-29

Similar Documents

Publication Publication Date Title
IS4975A (is) Aðferð til meðhöndlunar á hjartabilun
IS5218A (is) Staðgengar bensópýranafleiður til meðferðar á bólgu
IS2252B (is) Meðhöndlun á vatni
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
IS2261B (is) Aðferð til framleiðslu á 5-sýanóþalíði
FI20000863L (fi) Uusi hoitomenetelmä
IS2494B (is) Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni
IS5715A (is) Aðferð til smíði á 4-karboxýamínó-2-setnu-1,2,3,4-tetrahýdrókínólíni
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
IS2223B (is) Aðferð til framleiðslu á 5-sýanóþalíði
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
IS5149A (is) Aðferð til meðhöndlunar á plöntum með kímblöð
TR199901597A3 (tr) Kaplanmis peroksijen bilesikleri hazirlama yöntemi.
IS2296B (is) Aðferð til framleiðslu á vernduðu 4-amínómetýl-pýrrólidín-3-óni.
DE69926591D1 (de) Fehlersicherer Defribrillator
IS5126A (is) Aðferð til meðhöndlunar á plöntum með kímblöð
IS3004B (is) Aðferð til meðhöndlunar á svefnleysi á frumstigi
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
PT1051172E (pt) Metodo para tratamento da dpco
ZA987419B (en) Method for treating heart failure.
IS6098A (is) Ósantant til meðhöndlunar á skaptruflunum
IS5481A (is) Samsett meðferð til meðhöndlunar á alnæmi
NO307859B1 (no) FremgangsmÕte for beregning av varighet av oppkoblinger
IS2153B (is) S-nítrósóþíól til meðferðar við blóðrásartruflunum
IS5212A (is) Bætt aðferð til framleiðslu á pýrazólópýrimidínónafleiðu